| Factor Information | |
|---|---|
| Data ID | 2092 |
| Factor | length of stay in ICU |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To study the perioperative change in serum neutrophil gelatinase-associated lipocalin (NGAL) level among children with CHD |
| p Value | <0.05 |
| Conclusion | Length of stay in ICU with moderate PH-CHD was longer than that with non-PH CHD. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 581 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/PDA, ASD/VSD |
| Reference | |
|---|---|
| PMID | 24131832 |
| Year | 2013 |
| Title | Perioperative change in serum neutrophil gelatinase-associated lipocalin level among children with congenital heart disease and pulmonary hypertension |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Xinjiang, China | |
| Method | t-test | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | moderate PH(Treatment) | without PH(Control) |
| Number | 20 | 20 |
| Age | 5.4±3.5 years | 4.5±2.5 years |
| Gender (Male: Female) | 7:13 | 11:9 |
| Marker Level | 27.0±10.2 h | 18.7±3.5 h |
